Is Viking Therepautics a Buy Now?

The clinical-stage drugmaker is developing an anti-obesity drug that could go on to produce record-breaking sales.Shares of Viking Therapeutics (VKTX -13.36%) fell on Monday, Nov. 4, despite some encouraging new data. Over the weekend, the company showed the medical community and investors results that suggest its experimental anti-obesity tablet, tentatively named VK2735, could go on to generate blockbuster sales.Viking's previous positive results for the experimental treatments in its pipeline haven't gon ...